| Health / Medical Topics |
GVAX Prostate Cancer Vaccine
A whole cell vaccine expressing human granulocyte macrophage-colony stimulating factor (GM-CSF) with potential antineoplastic activity. Tumor cells from prostate cancer patients are harvested and then genetically modified to secrete GM-CSF, an immune stimulatory growth factor that plays a key role in stimulating the body's immune responses against tumor cells. Because the vaccine is derived from allogenic cells, it has demonstrated a favorable side effect profile than other approaches of delivering long-lasting GM-CSF. (NCI Thesaurus)
YOU MAY ALSO LIKE
An irradiated, autologous pancreatic cancer vaccine consisting of patient-specific pancreatic cancer cells genetically modified to secrete the cytokine granulocyte-macrophage colony stimulating factor…
An autologous lung cancer vaccine consisting of patient-specific lung cancer cells genetically modified to secrete granulocyte-macrophage colony stimulating factor (GM-CSF), an immunostimulatory…
GVAX cancer vaccines are autologous cell vaccines comprised of tumor cells which have been irradiated and genetically modified to secrete granulocyte-macrophage colony…
Antineoplastic vaccine being developed against liver cancer.
A country in northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.
A quassinoid phytochemical isolated from the plant Simaba guianensis with potential antineoplastic and antimalarial activities.
